MO - Altria Group, Inc.

NYSE - NYSE Delayed Price. Currency in USD
53.33
-0.62 (-1.15%)
At close: 4:02PM EST

53.48 +0.15 (0.28%)
After hours: 6:57PM EST

Stock chart is not supported by your current browser
Previous Close53.95
Open54.44
Bid53.48 x 900
Ask53.60 x 1400
Day's Range53.17 - 54.89
52 Week Range52.73 - 74.38
Volume9,310,723
Avg. Volume8,781,854
Market Cap100.21B
Beta (3Y Monthly)-0.14
PE Ratio (TTM)9.47
EPS (TTM)5.63
Earnings DateJan 30, 2019 - Feb 4, 2019
Forward Dividend & Yield3.20 (5.91%)
Ex-Dividend Date2018-09-13
1y Target Est65.09
Trade prices are not sourced from all markets
  • Canopy Growth best way to play Canadian cannabis
    CNBC Videosyesterday

    Canopy Growth best way to play Canadian cannabis

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • Canopy Growth still best way to play Canadian cannabis ev...
    CNBC Videosyesterday

    Canopy Growth still best way to play Canadian cannabis ev...

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • Business Wire7 hours ago

    Altria Declares Regular Quarterly Dividend of $0.80 per Common Share

    Altria Group, Inc. today announced that its Board of Directors declared a regular quarterly dividend of $0.80 per common share, payable on January 10, 2019, to shareholders of record as of December 26, 2018.

  • InvestorPlace14 hours ago

    Will Coca-Cola Stock Be the Next Giant to Fall?

    From here, Coca-Cola (NYSE:KO) looks badly overvalued. Coca-Cola stock is a classic long-term play, seemingly, but that alone doesn’t justify a stretched valuation. KO stock touched an all-time high just a couple of weeks ago.

  • Altria and Philip Morris: Do Dividend Yields Look Attractive?
    Market Realist10 hours ago

    Altria and Philip Morris: Do Dividend Yields Look Attractive?

    Will 2019 Be Better for Altria and Philip Morris? Dividends help smooth out return volatility for shareholders. Both Philip Morris International (PM) and Altria Group (MO) have a strong history of returning cash to shareholders.

  • What to Expect from Philip Morris’s Revenue in 2019
    Market Realist11 hours ago

    What to Expect from Philip Morris’s Revenue in 2019

    Analysts expect Philip Morris International’s (PM) revenue to rise by 2.7% to $29.54 billion in 2018. They expect the company’s revenue for 2019 to be at $30.33 billion, which represents YoY growth of 2.7% from 2018.

  • 3 Dividend Stocks That Pay You More Than Exxon Does
    Motley Fool12 hours ago

    3 Dividend Stocks That Pay You More Than Exxon Does

    Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.

  • GlobeNewswire12 hours ago

    Metrospaces (OTC:MSPC) Seize Upon Real Estate Market Opportunities in the Cannabis Space; Companies discussed: Aurora Cannabis, Cronos Group, Inc., Altria, Crop Infrastructure Corp.

    Investorideas.com, a leading investor news resource covering real estate and cannabis stocks, releases a snapshot looking at the synergistic opportunity for both sectors. As the emerging cannabis market explodes with increased legalization across North American markets, Metrospaces, Inc. (OTC:MSPC) Company Executive President Mr. Oscar Brito highlights the considerable market opportunities in real estate that many investors may have overlooked.

  • Why Are Analysts Expecting Altria’s Revenue to Rise in 2019?
    Market Realist13 hours ago

    Why Are Analysts Expecting Altria’s Revenue to Rise in 2019?

    Will 2019 Be Better for Altria and Philip Morris? Analysts are expecting Altria Group’s (MO) revenue to rise by 0.9% to $19.66 billion in 2018, while its revenue in 2019 is expected to increase by 1.5% to $19.95 billion. What will drive Altria’s sales?

  • Barrons.com14 hours ago

    Altria Might Have a Plan for a Cigarette-Free Future

    Altria’s announcement that it would invest in Canadian marijuana company Cronos Group got all the attention, but one analyst describes its decision to discontinue its own vaping products as “savvy.”

  • CNBCyesterday

    Cramer Remix: Don't waste your time with sector-based ETFs

    Jim Cramer uses the tech sector to make a case for picking individual stocks over risky exchange-traded funds.

  • Altria (MO) Gains As Market Dips: What You Should Know
    Zacksyesterday

    Altria (MO) Gains As Market Dips: What You Should Know

    Altria (MO) closed the most recent trading day at $53.95, moving +1.11% from the previous trading session.

  • Canopy Growth still best way to play Canadian cannabis even with Cronos-Altria deal: Cramer
    CNBCyesterday

    Canopy Growth still best way to play Canadian cannabis even with Cronos-Altria deal: Cramer

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • Altria Beats Philip Morris’s EPS Growth in First Three Quarters
    Market Realistyesterday

    Altria Beats Philip Morris’s EPS Growth in First Three Quarters

    Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Altria Group (MO) posted adjusted EPS of $3.04, which represents growth of 22.6% from $2.48 in the corresponding three quarters of the previous year. Also, the company has outperformed analysts’ EPS expectations in all three quarters.

  • Why New Age Beverages Stock Spiked Today
    Motley Foolyesterday

    Why New Age Beverages Stock Spiked Today

    Shares of the CBD beverage maker picked up steam for the second day in a row. Here's why.

  • Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
    Zacksyesterday

    Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest

    Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.

  • Philip Morris Has Outperformed Altria’s Revenue Growth in 2018
    Market Realistyesterday

    Philip Morris Has Outperformed Altria’s Revenue Growth in 2018

    Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Philip Morris International (PM) posted net revenue growth of 8.2%, outperforming Altria Group’s (MO) net revenue growth of 0.4%. During the period, Philip Morris posted net revenue of $22.13 billion compared to $20.45 billion in the first three quarters of 2017.

  • 12 Stocks You Should Never Sell
    Kiplingeryesterday

    12 Stocks You Should Never Sell

    Hopping in and out of stocks tends to do more harm than good to your portfolio. Fortunately, most of the time, investors are content to sit back and let time do the heavy lifting. Every now and then, however, an uninterrupted market-wide rally (such as the one we saw in 2017) followed by a couple of major corrections (such as the ones we've seen in 2018) inspires a more active approach. Buying every dip last year was a bulletproof strategy; steering clear of this year's big dips would've left most investors far better off. But broadly speaking, investors shouldn't embrace that short-term mindset. Buy-and-hold is a time-tested strategy that helps investors avoid trying to time the market (which even experts can't reliably do) and making poor emotional decisions. With that as a backdrop, here are a dozen stocks to never sell. Many buy-and-holders are looking to reset their portfolios as the new year begins. If you hold any of the stocks, don't stop ... and if you're looking to buy, be ready to commit. Each company has plenty to success that their history of success should continue for years to come. And each operates in an industry that won't go away anytime soon. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond

  • InvestorPlaceyesterday

    Did Altria Pay Too Much for Cronos Stock?

    Altria Group (NYSE:MO) is joining the mega-cap firms eager to hedge against a potential decline in their home business. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group (NASDAQ:CRON). Meanwhile, Constellation Brands (NYSE:STZ) bought Canopy Growth (NYSE:CGC) at the beginning of this year.

  • Can We Expect Upward Momentum in Altria and Philip Morris?
    Market Realistyesterday

    Can We Expect Upward Momentum in Altria and Philip Morris?

    Will 2019 Be Better for Altria and Philip Morris? 2018 has been tough for tobacco companies. The increased anti-tobacco regulations, the declining smoking population, and the rising competition in the RRP (reduced-risk products) space have been putting pressure on tobacco companies.

  • Altria Grossly Overpaid for Its Equity Stake in Pot Stock Cronos Group
    Motley Fool2 days ago

    Altria Grossly Overpaid for Its Equity Stake in Pot Stock Cronos Group

    Ponying up $1.8 billion for a 45% stake in Cronos could come back to haunt the maker of Marlboro cigarettes.

  • ACCESSWIRE2 days ago

    Stock Market Press Spotlight on Under-Served Multi-Billion Dollar Cannabis Real Estate Market: Metrospaces, Inc. (OTC: MSPC), Altria Group (NYSE: MO) and Tilray (NASDAQ: TLRY)

    NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Metrospaces, Inc. (OTC PINK: MSPC) is high atop Stock Market Press' list of companies targeting the highly lucrative cannabis real estate market. A major shift is taking place in the tobacco industry, as seen with the recent Altria (MO) acquisition of 45% of Cronos (NASDAQ listed) stock, turning tobacco into cannabis farmland. Altria announces $2.4B investment deal with Canadian cannabis company Cronos.

  • The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
    Zacks2 days ago

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

  • InvestorPlace2 days ago

    4 Reasons Why Aphria Stock Could Be an M&A Target Next

    Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.